Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-07

Clinical Trial Update: rhBMP-2 Versus Vivigen in Lumbar Fusion Procedures [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing rhBMP-2 to Vivigen in lumbar fusion procedures was terminated; results were posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ViviGen
  • rhBMP-2 (bone morphogenetic protein-2)

Snippet

Sponsor: Virtua Health, Inc. | Conditions: Lumbar Spine Degeneration | Phase 4 | Status: TERMINATED | Results posted: 2019-08-07